← Back to Search

Microwave Ablation

Microwave Ablation for Lung Cancer

N/A
Recruiting
Led By Jason Beattie, MD
Research Sponsored by Beth Israel Deaconess Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Target nodule/tumor which can be accessed via navigational bronchoscopy and confirmed location with cone beam CT scan intra-operatively
Participants must be at least 22 years old and able to provide consent
Must not have
Prior radiation or neo adjuvant chemotherapy of the target nodule/tumor
Patients with coagulopathy
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks
Awards & highlights

Summary

This trial is being done to see if the AveCure Flexible Microwave Ablation Probe is effective in destroying cancerous lung nodules that are up to 3 c m in size.

Who is the study for?
This trial is for adults over 22 with Stage I-II primary lung cancer, specifically solitary nodules up to 3 cm. They must have a confirmed type of malignancy and be candidates for surgery. Excluded are those with nodules under 1 cm, prior treatments on the nodule, contraindications to bronchoscopy, significant comorbidities, electronic implants, coagulopathy issues or participation in other lung cancer studies.
What is being tested?
The study tests the effectiveness of the AveCure Flexible Microwave Ablation Probe on destroying cancerous lung nodules up to 3 cm. It involves microwave ablation (MWA) using this probe through navigational bronchoscopy and cone beam CT scan confirmation during operation.
What are the potential side effects?
While specific side effects aren't listed here, generally microwave ablation can cause pain at the site of treatment, bleeding into the chest cavity or airways, collapse of part of a lung (pneumothorax), damage to surrounding organs or structures.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My tumor can be reached and checked with a special lung biopsy technique.
Select...
I am 22 years old or older and can give my consent.
Select...
I am eligible for surgery to remove part of my lung.
Select...
My lung cancer is in the early stages (Stage I or II) and involves a single nodule up to 3 cm.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My targeted tumor has been treated with radiation or chemotherapy before surgery.
Select...
I have a blood clotting disorder.
Select...
I cannot undergo a flexible bronchoscopy due to health reasons.
Select...
I cannot undergo a bronchoscopy due to intolerance.
Select...
I am currently COVID-19 positive.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Pathological changes in the tumor tissue.
Rate of Planned Ablations.
Secondary study objectives
Histological changes in lung tissue outside the zone of predicted ablation.
Immune-histochemical changes in the tumor tissue.

Trial Design

1Treatment groups
Experimental Treatment
Group I: AVECURE FLEXIBLE MICROWAVE ABLATION PROBE FOR LUNG NODULESExperimental Treatment1 Intervention
The research study procedures include screening for eligibility and study treatment including evaluations and follow up visits. * Ablation Procedure- MWA will be used to treat solitary pulmonary nodules up to 3cm. * CT scan will then be performed to evaluate the radiological changes 2 - 4 weeks after the ablation procedure. * Surgery will be performed to remove the lung nodule and the tissue will be evaluated by pathology.

Find a Location

Who is running the clinical trial?

Beth Israel Deaconess Medical CenterLead Sponsor
848 Previous Clinical Trials
12,930,094 Total Patients Enrolled
Dana-Farber Cancer InstituteOTHER
1,100 Previous Clinical Trials
353,087 Total Patients Enrolled
MedWaves, IncUNKNOWN
1 Previous Clinical Trials
10 Total Patients Enrolled

Media Library

AveCure Flexible Microwave Ablation Probe (Microwave Ablation) Clinical Trial Eligibility Overview. Trial Name: NCT05281237 — N/A
Lung Cancer Research Study Groups: AVECURE FLEXIBLE MICROWAVE ABLATION PROBE FOR LUNG NODULES
Lung Cancer Clinical Trial 2023: AveCure Flexible Microwave Ablation Probe Highlights & Side Effects. Trial Name: NCT05281237 — N/A
AveCure Flexible Microwave Ablation Probe (Microwave Ablation) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05281237 — N/A
~3 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top